Simple, quantitative primer-extension PCR assay for direct monitoring of microRNAs and short-interfering RNAs

  1. CHRISTOPHER K. RAYMOND,
  2. BRIAN S. ROBERTS,
  3. PHILLIP GARRETT-ENGELE,
  4. LEE P. LIM, and
  5. JASON M. JOHNSON
  1. Rosetta Inpharmatics, A wholly owned subsidiary of Merck & Co., Inc., Seattle, Washington 98109, USA

Abstract

There has been a surge of interest in the biology of microRNAs and the technology of RNA interference. We describe a simple, robust, inexpensive assay for quantitative analysis of microRNAs and short-interfering RNAs. The method relies on primer extension conversion of RNA to cDNA by reverse transcription followed by quantitative, real-time PCR. Technical parameters critical to the success of the assay are presented. Measurements of microRNA levels are sensitive, with most assays allowing measurements in the femtomolar range, which corresponds to tens of copies per cell or less. The assay has a high dynamic range and provides linear readout over differences in microRNA concentrations that span 6–7 orders of magnitude. The assay is capable of discriminating between related microRNA family members that differ by subtle sequence differences. We used the method for quantitative analysis of six microRNAs across 12 tissue samples. The data confirm striking variation in the patterns of expression of these noncoding regulatory RNAs.

Keywords

Footnotes

| Table of Contents